{
    "paper_id": "c395fb9295efe4251d60696afa3f9274d1b0295b",
    "metadata": {
        "title": "Journal Pre-proof Universal testing of patients and their support persons for COVID-19 when presenting for admission to Labor and Delivery within the Mount Sinai Health System",
        "authors": [
            {
                "first": "Ayisha",
                "middle": [],
                "last": "Buckley",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Angela",
                "middle": [],
                "last": "Bianco",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Joanne",
                "middle": [],
                "last": "Stone",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome 2 (SARS-8 CoV-2) virus has been declared a pandemic by the World Health Organization (WHO) (1) . It spread at an 9 accelerated rate in densely populated regions such as NYC which is considered an epicenter. ",
            "cite_spans": [
                {
                    "start": 175,
                    "end": 178,
                    "text": "(1)",
                    "ref_id": "BIBREF0"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "We explored concordance/discordance rates between patients and support persons. Among 26 SARS-CoV 2 infected patients, 23/28 (82.1%) support persons were infected. However only 16/171 27 (9.4%) support persons were infected when patients tested negative. Importantly COVID negative 28 patients had COVID positive support persons 6.2% of the time. (Table 1) ",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 347,
                    "end": 356,
                    "text": "(Table 1)",
                    "ref_id": "TABREF1"
                }
            ],
            "section": "25"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "New York State Department of Health",
            "authors": [],
            "year": null,
            "venue": "Coronavirus disease 2019",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Universal testing of patients and their support persons for COVID-19 when presenting for 3 admission to Labor and Delivery within the Mount Sinai Health System",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Mount Sinai Health System, we began to care for pregnant women with COVID -19 in 12 March of 2020. In April 2020 a policy was implemented to perform universal SARS-CoV 2 testing for 13 women planning to deliver within the Mount Sinai Health system, as well as their designated support 14 persons so as to inform obstetric and neonatal practices. 15 16 During the testing interval of April 4-15, 2020, 307 asymptomatic women presenting in labor to 17 two institutions within Mount Sinai Health System, underwent SARS-CoV 2 testing. Among the 307 18 women tested, 50 SARS CoV-2 infections were detected. The prevalence of asymptomatic infection in 19 this group was 50/307 (16.3%). Among these women 91 did not have a support person present. Of the 20 remaining 216 support persons 17 declined testing leaving 199 available for testing. All support persons 21 were administered an infectious screening tool upon entry and all screened negative (2). Of these 199 22 support persons who underwent SARS-CoV 2 testing 39 were infected with a prevalence of 19.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "this corresponds to a difference in the risk of the support person being positive of 72.these findings, it is apparent that there was a high proportion of asymptomatic COVID-33 19 infected patients and support persons at the height of the pandemic in N.Y.C hospitals. Our data 34 suggests that universal testing of patients and support persons may direct use of PPE and more 35 adequately protect health care workers. Testing of support persons may also impact newborn care 36 precautions. Additionally, the results of SARS-CoV-2 testing informs how patients are cohorted on 37 postpartum units offering protection to uninfected women and newborns. Given the high rate of 38 asymptomatic infected maternity patients and support persons, universal testing provides",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "There are no financial disclosures and the authors report no conflicts of interest Ayisha Buckley, M.D. Icahn School of Medicine at Mount Sinai Hospital 22 Department of Obstetrics, Gynecology, and Reproductive Medicine 23 5 E 98 St NY, 2 nd floor, Department of Obstetrics, Gynecology, and Reproductive Medicine NY 10029 Title: Universal testing of patients and their support persons for COVID-19 when presenting for admission to Labor and Delivery within the Mount Sinai Health System",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Support Persons COVID-19 Test Results Overall based on Patient Results 55 56 Delivery Type Patient Result Note: 91 patients did not have a support person present. Of the remaining 216 support persons 17 declined testing leaving 199",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}